These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 2051028

  • 1. Nonrandom selection of T cell specificities in anti-HLA-DR responses. Sequence motifs of the responder HLA-DR allele influence T cell recruitment.
    Weyand CM, Hicok KC, Goronzy JJ.
    J Immunol; 1991 Jul 01; 147(1):70-8. PubMed ID: 2051028
    [Abstract] [Full Text] [Related]

  • 2. Restrictions in the repertoire of allospecific T cells. Contribution of the alpha-helical sequence polymorphism of HLA-DR molecules.
    Goronzy JJ, Xie C, Hu W, Lundy SK, Weyand CM.
    J Immunol; 1993 Jul 15; 151(2):825-36. PubMed ID: 8335912
    [Abstract] [Full Text] [Related]

  • 3. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
    Flament C, Benmerah A, Bonneville M, Triebel F, Mami-Chouaib F.
    J Immunol; 1994 Oct 01; 153(7):2890-904. PubMed ID: 8089476
    [Abstract] [Full Text] [Related]

  • 4. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
    Busch R, Hill CM, Hayball JD, Lamb JR, Rothbard JB.
    J Immunol; 1991 Aug 15; 147(4):1292-8. PubMed ID: 1869824
    [Abstract] [Full Text] [Related]

  • 5. Evolution of the HLA-DR1 gene family. Structural and functional analysis of the new allele "DR-BON".
    Coppin HL, Avoustin P, Fabron J, Huchenq A, Garnier JM, Thomsen M, De Preval C.
    J Immunol; 1990 Feb 01; 144(3):984-9. PubMed ID: 1688595
    [Abstract] [Full Text] [Related]

  • 6. Disease-associated human histocompatibility leukocyte antigen determinants in patients with seropositive rheumatoid arthritis. Functional role in antigen-specific and allogeneic T cell recognition.
    Weyand CM, Goronzy JJ.
    J Clin Invest; 1990 Apr 01; 85(4):1051-7. PubMed ID: 1690755
    [Abstract] [Full Text] [Related]

  • 7. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both "dominant" and "cryptic": evidence for allele-specific processing.
    de Koster HS, van Rood JJ, Termijtelen A.
    Eur J Immunol; 1992 Jun 01; 22(6):1531-9. PubMed ID: 1376262
    [Abstract] [Full Text] [Related]

  • 8. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones.
    Geiger MJ, Gorski J, Eckels DD.
    J Immunol; 1991 Oct 01; 147(7):2082-7. PubMed ID: 1833450
    [Abstract] [Full Text] [Related]

  • 9. Position 71 in the alpha helix of the DR beta domain is predicted to influence peptide binding and plays a central role in allorecognition.
    Coppin HL, Carmichael P, Lombardi G, L'Faqihi FE, Salter R, Parham P, Lechler RI, de Preval C.
    Eur J Immunol; 1993 Feb 01; 23(2):343-9. PubMed ID: 8436170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP, Bach FH, Wu SK.
    J Immunol; 1988 May 15; 140(10):3631-9. PubMed ID: 3129499
    [Abstract] [Full Text] [Related]

  • 13. Polymorphic HLA-DR7 beta 1 chain residues that are involved in T cell allorecognition.
    Rosen-Bronson S, Yu WY, Karr RW.
    J Immunol; 1991 Jun 15; 146(12):4264-70. PubMed ID: 2040801
    [Abstract] [Full Text] [Related]

  • 14. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae.
    Mustafa AS, Qvigstad E.
    Int J Lepr Other Mycobact Dis; 1989 Mar 15; 57(1):1-11. PubMed ID: 2659694
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human anti-porcine xenogeneic T cell response. Evidence for allelic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition.
    Yamada K, Sachs DH, DerSimonian H.
    J Immunol; 1995 Dec 01; 155(11):5249-56. PubMed ID: 7594537
    [Abstract] [Full Text] [Related]

  • 17. A novel T-cell-defined HLA-DR polymorphism not predicted from the linear amino acid sequence.
    Termijtelen A, van den Elsen P, Koning F, de Koster S, Schroeijers W, Vanderkerckhove B.
    Hum Immunol; 1989 Sep 01; 26(1):47-58. PubMed ID: 2476425
    [Abstract] [Full Text] [Related]

  • 18. Mapping of distinct serologic and T cell recognition epitopes on an HLA-DR beta-chain.
    Gorski J, Radka SF, Masewicz S, Mickelson EM.
    J Immunol; 1990 Oct 01; 145(7):2020-4. PubMed ID: 1697874
    [Abstract] [Full Text] [Related]

  • 19. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation.
    Hurley CK, Steiner N, Wagner A, Geiger MJ, Eckels DD, Rosen-Bronson S.
    J Immunol; 1993 Feb 15; 150(4):1314-24. PubMed ID: 8381833
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.